Back
BullFrog AI
IPOBFAI.NASDAQPast

BullFrog AI

Biotech AI

Company website ↗
Foundation year: 2020
IPO date
13/02/2023

About

BullFrog AI Holdings, Inc. is an innovative company that uses machine learning and artificial intelligence to develop pharmaceuticals. The company conducts its own research programs on drug molecules across four different areas, but its main market is providing services to external developers, which is valued at over $47 billion.

BullFrog has its own AI/ML platform called bfLEA, which was developed by scientists at Johns Hopkins University. It uses various types of machine learning that are capable of identifying significant relationships between potentially effective molecules and biochemical processes.

One advantage of bfLEA is its ability to work with minimal human involvement and without the need for a prior hypothesis. In other words, bfLEA can work with unprocessed and unlabeled datasets, identifying potentially useful hidden patterns of interaction. This increases the likelihood of discovering fundamentally new directions for treating a variety of diseases.
___________________________

Number of employees:

4-10
___________________________

Headquarters:

Boyd's, Maryland, USA

Underwriters

TEDCO